Department of Radiology

Publications

2023

Jeitner TM, Azcona JA, Ables GP, Cooke D, Horowitz MC, Singh P, et al. Cystine rather than cysteine is the preferred substrate for β-elimination by cystathionine γ-lyase: implications for dietary methionine restriction. Geroscience. 2023.

Carnevale JA, Pandey A, Ramirez-Loera C, Goldberg JL, Bander ED, Henderson F, et al. Endonasal, supraorbital, and transorbital approaches: minimal access endoscope-assisted surgical approaches for meningiomas in the anterior and middle cranial fossae. J Neurosurg. 2023:1-9.

Solomon E. A Phase II Trial Evaluating Rapid Mid-Treatment Nodal Shrinkage to Select for Adaptive Deescalation in p16+ Oropharyngeal Cancer Patients Undergoing Definitive Chemoradiation.. 2023.

Ahad A, Saeed HK, Del Solar V, López-Hernández JE, Michel A, Mathew J, et al. Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model. ACS Pharmacol Transl Sci. 2023;6(12):1972-1986.

Prince MR, Laifer-Narin S, Chong J. Editorial for "Deep Learning of Placenta Accreta". J Magn Reson Imaging. 2023.

Holste G, Zhou Y, Wang S, Jaiswal A, Lin M, Zhuge S, et al. Towards long-tailed, multi-label disease classification from chest X-ray: Overview of the CXR-LT challenge. ArXiv. 2023.

Cao E, Ma D, Nayak S, Duong TQ. Deep learning combining FDG-PET and neurocognitive data accurately predicts MCI conversion to Alzheimer's dementia 3-year post MCI diagnosis. Neurobiol Dis. 2023;187:106310.

Wright K, van Rossum EF, Zan E, Werner N, Harris A, Feelders RA, et al. Emerging diagnostic methods and imaging modalities in cushing's syndrome. Front Endocrinol (Lausanne). 2023;14:1230447.

Kim H, Kang SW, Kim J-, Nagar H, Sabuncu M, Margolis DJ, et al. The role of AI in prostate MRI quality and interpretation: Opportunities and challenges. Eur J Radiol. 2023;165:110887.

Xu T, Schulga A, Konovalova E, Rinne SS, Zhang H, Vorontsova O, et al. Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model. Int J Mol Sci. 2023;24(3).